Indian Pharma Industry in 2020_An essay by Kishor M. R.
China-India joint summit discusses bilateral trade to improve pharma industry
The China-India joint summit held recently discussed bilateral trade to improve Indo- China pharma industry and address issues like long product registration time and high fees for product registration in China’s drug regulatory system, among other issues. Besides this, other relevant key issues related to transparency in public procurement system in China and clinical trial related approvals were also deliberated at the summit organised under the aegis of Indian Pharmaceutical Association (IPA), Shengjie and SaSPinjara, China between May 16 and May 17, 2019 at Pullman Shanghai South, China. The summit was focused on enhancing export business for both the nations across the globe. Senior health ministry official from Government of Gujarat Punamchand Parmar was invited as the Chief Guest of the summit and Gujarat Food and Drugs Control Administration (FDCA) Commissioner Dr Hemant Koshia was invited as Guest of Honour. Among other dignitaries, Dr. Anil Kumar Rai, Consulate General of
I have been following you for several years and have learned a few things. So thanks for your stories, opinions, and thoughts on all the things you have written about. It is always fun to see what goes on in different worlds, the things we have in common and the things we don’t. Have a good life, whatever you do!Thank you so much, Ive enjoyed the ride!
ReplyDeleteHello,
ReplyDeleteIt was a very nicely written article. I like to read it. It was totally informative and topic you covered here, I am totally agreed with you. I must say that I have learnt so many things from it.
Thank you for sharing this article. Keep writing. Thank you so much.